80023077: Advances in the Diagnosis and Treatment of the Rheumatic Diseases (EM 2009)

TO VIEW THE PRESENTATIONS:
PLEASE CLICK HERE

Accreditation Statement:
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement:
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 15.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Description:
Now in its fifth year, this symposium has been planned for the providers of care to patients with rheumatic diseases. Given the wide variety of rheumatologic disorders, and an ever-increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.

Target Audience
This activity is intended for Internists, Orthopedic Surgeons and Rheumatologists.

Objectives:
Following this activity, the participant will demonstrate the ability to:
• Discuss recent advances in the use of biologic agents in the treatment of rheumatoid arthritis
• Appreciate the unique challenges associated with transitioning the pediatric rheumatic disease patient into adult practice
• Discuss new and emerging issues in the management of gout
• Recognize the major issues related to the management of the pregnant rheumatic disease patient
• Recognize the major ophthalmologic manifestations of the rheumatic diseases
• Diagnose and manage common pulmonary manifestations of the rheumatic diseases
• Discuss current management approaches and controversies in the diagnosis and treatment of giant cell arteritis

Notice About Off-Label Use Presentations
The Johns Hopkins University School of Medicine/ Advances in the Diagnosis and Treatment of Rheumatic Diseases 2009 (EM) may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. The Johns Hopkins University School of Medicine is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations on off-label uses, does not imply an endorsement by Johns Hopkins of the uses, products, or techniques presented.

Copyright Information
All rights reserved. No part of this syllabus may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Instructions to obtain a CME Certificate for this activity.:

You must register online at this site using the Registration Tab link above pay the $35 registration fee. Once registered, you will be required to complete the Activity Evaluation, and then can take the post test for each session for which you would like a CME certificate.

Links to the individual post tests and the activity evaluation will appear in your Learning Schedule.

To access your Learning Schedule:
-Make sure you are loged into the CME website.
-Click Learning Schedule in the navigation box on the top left hand side of the screen.
-On the next page, click the link labeled "Online and Enduring"
-Complete the online Activity Evaluation, using the link labeled "Complete Evaluation".
-The available post tests will appear after you put a check in the checkbox next to "Display available sessions…".

To take a post-test, click the link labeled "Complete Post Test (required)" next to the session for which you would like a CME certificate. Please note a passing score must be received and a link will appear to print your certificate.

Release Date: August 10, 2009
Expiration Date: August 9, 2011
Registrations will not be accepted after September 24, 2011.

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.